Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

A customizable microfluidic platform for medium-throughput modeling of neuromuscular circuits.

Bellmann J, Goswami RY, Girardo S, Rein N, Hosseinzadeh Z, Hicks MR, Busskamp V, Pyle AD, Werner C, Sterneckert J.

Biomaterials. 2019 Dec;225:119537. doi: 10.1016/j.biomaterials.2019.119537. Epub 2019 Oct 8.

2.

Challenges in microRNAs' targetome prediction and validation.

Rojo Arias JE, Busskamp V.

Neural Regen Res. 2019 Oct;14(10):1672-1677. doi: 10.4103/1673-5374.257514.

3.

Retinal miRNA Functions in Health and Disease.

Zuzic M, Rojo Arias JE, Wohl SG, Busskamp V.

Genes (Basel). 2019 May 17;10(5). pii: E377. doi: 10.3390/genes10050377. Review.

4.

Highly Conductive, Stretchable, and Cell-Adhesive Hydrogel by Nanoclay Doping.

Tondera C, Akbar TF, Thomas AK, Lin W, Werner C, Busskamp V, Zhang Y, Minev IR.

Small. 2019 Jul;15(27):e1901406. doi: 10.1002/smll.201901406. Epub 2019 Apr 26.

5.

FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy.

Marrone L, Drexler HCA, Wang J, Tripathi P, Distler T, Heisterkamp P, Anderson EN, Kour S, Moraiti A, Maharana S, Bhatnagar R, Belgard TG, Tripathy V, Kalmbach N, Hosseinzadeh Z, Crippa V, Abo-Rady M, Wegner F, Poletti A, Troost D, Aronica E, Busskamp V, Weis J, Pandey UB, Hyman AA, Alberti S, Goswami A, Sterneckert J.

Acta Neuropathol. 2019 Jul;138(1):67-84. doi: 10.1007/s00401-019-01998-x. Epub 2019 Apr 1.

6.

Induced Neurons for the Study of Neurodegenerative and Neurodevelopmental Disorders.

Sauter EJ, Kutsche LK, Klapper SD, Busskamp V.

Methods Mol Biol. 2019;1942:101-121. doi: 10.1007/978-1-4939-9080-1_9.

PMID:
30900179
7.

Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis.

Kutsche LK, Gysi DM, Fallmann J, Lenk K, Petri R, Swiersy A, Klapper SD, Pircs K, Khattak S, Stadler PF, Jakobsson J, Nowick K, Busskamp V.

Cell Syst. 2018 Oct 24;7(4):438-452.e8. doi: 10.1016/j.cels.2018.08.011. Epub 2018 Oct 3.

8.

On-demand optogenetic activation of human stem-cell-derived neurons.

Klapper SD, Sauter EJ, Swiersy A, Hyman MAE, Bamann C, Bamberg E, Busskamp V.

Sci Rep. 2017 Oct 31;7(1):14450. doi: 10.1038/s41598-017-14827-6.

9.

[Optogenetics: A Therapeutic Option for Advanced Retinal Dystrophies].

Swiersy A, Klapper SD, Busskamp V.

Klin Monbl Augenheilkd. 2017 Mar;234(3):335-342. doi: 10.1055/s-0043-101820. Epub 2017 Mar 2. Review. German.

10.

Functional Maturation of Human Stem Cell-Derived Neurons in Long-Term Cultures.

Lam RS, Töpfer FM, Wood PG, Busskamp V, Bamberg E.

PLoS One. 2017 Jan 4;12(1):e0169506. doi: 10.1371/journal.pone.0169506. eCollection 2017.

11.

Vision Restoration Becomes Druggable.

Klapper SD, Busskamp V.

Neuron. 2016 Oct 5;92(1):3-5. doi: 10.1016/j.neuron.2016.09.030.

12.

Biophysical Properties of Optogenetic Tools and Their Application for Vision Restoration Approaches.

Klapper SD, Swiersy A, Bamberg E, Busskamp V.

Front Syst Neurosci. 2016 Sep 2;10:74. doi: 10.3389/fnsys.2016.00074. eCollection 2016. Review.

13.

Retinal Organoids from Pluripotent Stem Cells Efficiently Recapitulate Retinogenesis.

Völkner M, Zschätzsch M, Rostovskaya M, Overall RW, Busskamp V, Anastassiadis K, Karl MO.

Stem Cell Reports. 2016 Apr 12;6(4):525-538. doi: 10.1016/j.stemcr.2016.03.001. Epub 2016 Mar 31.

14.

Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes.

Bhatt S, Gupta MK, Khamaisi M, Martinez R, Gritsenko MA, Wagner BK, Guye P, Busskamp V, Shirakawa J, Wu G, Liew CW, Clauss TR, Valdez I, El Ouaamari A, Dirice E, Takatani T, Keenan HA, Smith RD, Church G, Weiss R, Wagers AJ, Qian WJ, King GL, Kulkarni RN.

Cell Metab. 2015 Aug 4;22(2):239-52. doi: 10.1016/j.cmet.2015.07.015.

15.

Rapid neurogenesis through transcriptional activation in human stem cells.

Busskamp V, Lewis NE, Guye P, Ng AH, Shipman SL, Byrne SM, Sanjana NE, Murn J, Li Y, Li S, Stadler M, Weiss R, Church GM.

Mol Syst Biol. 2014 Nov 17;10:760. doi: 10.15252/msb.20145508.

16.

Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter.

Cronin T, Vandenberghe LH, Hantz P, Juttner J, Reimann A, Kacsó AE, Huckfeldt RM, Busskamp V, Kohler H, Lagali PS, Roska B, Bennett J.

EMBO Mol Med. 2014 Sep;6(9):1175-90. doi: 10.15252/emmm.201404077.

17.

miRNAs 182 and 183 are necessary to maintain adult cone photoreceptor outer segments and visual function.

Busskamp V, Krol J, Nelidova D, Daum J, Szikra T, Tsuda B, Jüttner J, Farrow K, Scherf BG, Alvarez CP, Genoud C, Sothilingam V, Tanimoto N, Stadler M, Seeliger M, Stoffel M, Filipowicz W, Roska B.

Neuron. 2014 Aug 6;83(3):586-600. doi: 10.1016/j.neuron.2014.06.020. Epub 2014 Jul 4.

18.

Noninvasive optical inhibition with a red-shifted microbial rhodopsin.

Chuong AS, Miri ML, Busskamp V, Matthews GA, Acker LC, Sørensen AT, Young A, Klapoetke NC, Henninger MA, Kodandaramaiah SB, Ogawa M, Ramanlal SB, Bandler RC, Allen BD, Forest CR, Chow BY, Han X, Lin Y, Tye KM, Roska B, Cardin JA, Boyden ES.

Nat Neurosci. 2014 Aug;17(8):1123-9. doi: 10.1038/nn.3752. Epub 2014 Jul 6.

19.

[Retinitis pigmentosa: eye sight restoration by optogenetic therapy].

Roska B, Busskamp V, Sahel JA, Picaud S.

Biol Aujourdhui. 2013;207(2):109-21. doi: 10.1051/jbio/2013011. Epub 2013 Oct 10. Review. French.

PMID:
24103341
20.

Optogenetic therapy for retinitis pigmentosa.

Busskamp V, Picaud S, Sahel JA, Roska B.

Gene Ther. 2012 Feb;19(2):169-75. doi: 10.1038/gt.2011.155. Epub 2011 Oct 13. Review.

PMID:
21993174
21.

Optogenetic approaches to restoring visual function in retinitis pigmentosa.

Busskamp V, Roska B.

Curr Opin Neurobiol. 2011 Dec;21(6):942-6. doi: 10.1016/j.conb.2011.06.001. Epub 2011 Jun 25. Review.

PMID:
21708457
22.

Gene therapy in ophthalmology: validation on cultured retinal cells and explants from postmortem human eyes.

Fradot M, Busskamp V, Forster V, Cronin T, Léveillard T, Bennett J, Sahel JA, Roska B, Picaud S.

Hum Gene Ther. 2011 May;22(5):587-93. doi: 10.1089/hum.2010.157. Epub 2011 Feb 26.

PMID:
21142470
23.

Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa.

Busskamp V, Duebel J, Balya D, Fradot M, Viney TJ, Siegert S, Groner AC, Cabuy E, Forster V, Seeliger M, Biel M, Humphries P, Paques M, Mohand-Said S, Trono D, Deisseroth K, Sahel JA, Picaud S, Roska B.

Science. 2010 Jul 23;329(5990):413-7. doi: 10.1126/science.1190897. Epub 2010 Jun 24.

24.

Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs.

Krol J, Busskamp V, Markiewicz I, Stadler MB, Ribi S, Richter J, Duebel J, Bicker S, Fehling HJ, Schübeler D, Oertner TG, Schratt G, Bibel M, Roska B, Filipowicz W.

Cell. 2010 May 14;141(4):618-31. doi: 10.1016/j.cell.2010.03.039.

25.

Genetically timed, activity-sensor and rainbow transsynaptic viral tools.

Boldogkoi Z, Balint K, Awatramani GB, Balya D, Busskamp V, Viney TJ, Lagali PS, Duebel J, Pásti E, Tombácz D, Tóth JS, Takács IF, Scherf BG, Roska B.

Nat Methods. 2009 Feb;6(2):127-30. doi: 10.1038/nmeth.1292. Epub 2009 Jan 4.

PMID:
19122667
26.

KAP1-mediated epigenetic repression in the forebrain modulates behavioral vulnerability to stress.

Jakobsson J, Cordero MI, Bisaz R, Groner AC, Busskamp V, Bensadoun JC, Cammas F, Losson R, Mansuy IM, Sandi C, Trono D.

Neuron. 2008 Dec 10;60(5):818-31. doi: 10.1016/j.neuron.2008.09.036.

27.

Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration.

Lagali PS, Balya D, Awatramani GB, Münch TA, Kim DS, Busskamp V, Cepko CL, Roska B.

Nat Neurosci. 2008 Jun;11(6):667-75. doi: 10.1038/nn.2117. Epub 2008 Apr 27.

PMID:
18432197

Supplemental Content

Loading ...
Support Center